ARG54354

anti-DRAK1 antibody

anti-DRAK1 antibody for ICC/IF,Western blot and Human

Cell Biology and Cellular Response antibody; Cell Death antibody; Signaling Transduction antibody

Overview

Product Description Rabbit Polyclonal antibody recognizes DRAK1
Tested Reactivity Hu
Tested Application ICC/IF, WB
Specificity This antibody recognizes human DRAK1 (50kDa). No cross-reactivity with DRAK2, DAP or ZIP kinases.
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name DRAK1
Antigen Species Human
Immunogen Peptide corresponding to aa 5-19 of human DRAK1 (accession no. Q9UEE5).
Conjugation Un-conjugated
Alternate Names EC 2.7.11.1; DRAK1; Serine/threonine-protein kinase 17A; DAP kinase-related apoptosis-inducing protein kinase 1

Application Instructions

Application Suggestion
Tested Application Dilution
ICC/IF2-20 μg/mL
WB1 μg/mL
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control A431 and MOLT4

Properties

Form Liquid
Purification Immunoaffinity chroma-tography
Buffer PBS (pH 7.4) and 0.02% Sodium azide
Preservative 0.02% Sodium azide
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 9263 Human STK17A

Swiss-port # Q9UEE5 Human Serine/threonine-protein kinase 17A

Gene Symbol STK17A
Gene Full Name serine/threonine kinase 17a
Background Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis have been identified and designated DRAK1 and DRAK2 for DAP kinase–related apoptosis-inducing protein kinases. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases which mediate apoptosis through their catalytic activities. DRAK1 is located in cell nuclei, and the mRNA for DRAK1 is ubiquitously expressed in human tissues.
Function Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species. [UniProt]
Research Area Cell Biology and Cellular Response antibody; Cell Death antibody; Signaling Transduction antibody
Calculated MW 47 kDa
PTM Autophosphorylated.